Authors


Jordan Tapley

Latest:

Standardizing Site Clinical Trial Management with the eISF Reference Model

Clinical research sites feel growing pressure to perform work in a compliant manner while keeping pace with stakeholder information exchange workstreams, but lack the consistent processes to do so.


Yun Lu, PhD, Susan Li, Sarah Lawrence, and Sowmya Kaur

Latest:

Technology-Enabled Real-World Data and Clinical Research Data Integration in a Clinical Registry Ecosystem for Foundations

Spearheaded by disease foundations, the creation of clinical registries is streamlining data collection and driving informed decisions.


Deepu Joseph

Latest:

How Does FSP Models Complement eSource Implementation?

Biometric functional services, more than any other, can have a significant impact through the standardization of data collection and management.


Behtash Bahador

Latest:

Sharing Clinical Trial Results with Pediatric Participants

Survey uncovers pediatric-patient perspectives on plain language summaries.


Jen Lamppa

Latest:

Putting Diversity at the Center of Clinical Trials With Real-World Data

Robust data sets which can effectively represent diverse populations are key to driving greater inclusivity in trials.


Christine Bahls

Latest:

In Focus: Rethinking the Complex Process for Cancer Trials

Faced with a host of variables inherent to oncology studies, researchers look to inventive ways to boost efficiencies—and hopeful improved patient access.


Joel Morse

Latest:

How Healthcare Economics Outcomes Evidence Can Pave the Way for Digital Therapeutics

In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.


Masoud Jamei, PhD

Latest:

Accelerating the Progress of Kinase Inhibitors in Oncology

The potential of PBPK modeling in answering key questions around these drugs.


Lars Fransson

Latest:

eSource Interoperability Between EHR and EDC

Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.


Jim Reilly

Latest:

How Digital Will Transform Product Development in 2022 and Beyond

Pandemic sparks new long-term plan for success in R&D.


Alexey Aleshin

Latest:

Pandemic-Proof Clinical Study Start-Up

The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.


Marta Biase

Latest:

How Sponsors Can Use Health Decision Science to Improve Clinical Trial Recruitment and Retention

Examining the behaviors of clinical trial stakeholders to better understand challenges in patient participation.


Vijaya Prajwala

Latest:

Targeting Patient Population

Keys to ensuring your clinical trials better reflect your target population.



Teresa Montes

Latest:

Best Practices for Clinical Trial Technology Integration

Data is the heart of clinical trials, so life sciences firms need to integrate their technology to keep data sources and trial portfolios up-to-date and secure.



Raj Indupuri

Latest:

Enabling Digital Transformation: Managing External Clinical Data Sources to Advance Drug Development

With an increasing amount of diverse data that must now be collected and analyzed, the industry is faced with increasingly complex studies that present new challenges in data management.


Ross Weaver

Latest:

Where Do We Go From Here?

Lessons from six months of conducting clinical trials during the COVID-19 pandemic


Flatiron Health

Latest:

Transforming Prospective Study Data Acquisition & Delivery

Learn how your team can use EHR-to-EDC technology to reduce data monitoring costs, speed up data cleaning timelines, and hit study milestones faster.


Michael Shipton

Latest:

Is There a Positive Return on Investment on a Virtual Site?

Anticipating the need for both virtual and traditional sites during the planning process can provide high ROI for sponsors.


Jane Z. Reed

Latest:

NLP Analyzes the Past to Inform the Future of Clinical Trial Design

Natural language processing can help simplify protocols of the past, as evidenced by a recent Novartis initiative.


Bernard Vrijens

Latest:

DCT Risk/Benefit Profile: A Focus on Adherence

Assessing the benefits of digital adherence monitoring for sites and patients.


Ashley Davidson

Latest:

Fast Tracking Study Start-Up from Site Selection to First-Patient Enrollment

With a major wave of post-COVID trial starts on the horizon, the industry’s need to accelerate clinical research through study start-up is intensifying.



Vincent Keunen

Latest:

Navigating a Digital-Era Shift to Patient-Mediated Research

The potential of personal health records to bridge the gap between research and care.


Lou Guffroy

Latest:

Towards a Global Implementation of eConsent in Clinical Trials

All stakeholders must play part in increasing implementation.


Moulik Shah

Latest:

Assessing Sponsor and CRO Awareness

Improving receptivity and response to the evolving nature of clinical trial patient oversight.


Anastasia Zaitseva

Latest:

Trials During the Pandemic: A CRO's Perspective

Findings from an OCT Clinical survey of researchers from 61 sites in Russia to gain the perspective of an investigator regarding clinical trials during the COVID-19 pandemic.


Richard Horgan

Latest:

Improving Drug Development for Rare Patients Post-COVID

Non-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.


Clarivate Cortellis

Latest:

The Future of Precision Medicine: How Biomarkers Have Influenced Clinical Trial Designs and Outcomes

Planning a clinical trial for precision medicine is markedly more challenging than more conventional treatments, as it must consider patients' variability in genes. Join our webinar to learn how to design a successful precision medicine trial. Live: Wednesday, Oct. 14, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On demand available after airing until Oct. 14, 2021.

© 2024 MJH Life Sciences

All rights reserved.